Individual differences |
Methods | Statistics | Clinical | Educational | Industrial | Professional items | World psychology |
In the developed world, most blood donors are unpaid volunteers who give blood for a community supply. In poorer countries, established supplies are limited and donors usually give blood when family or friends need a transfusion. Many donors donate as an act of charity, but some are paid and in some cases there are incentives other than money such as paid time off from work. A donor can also have blood drawn for their own future use. Donating is relatively safe, but some donors have bruising where the needle is inserted or may feel faint.
Potential donors are evaluated for anything that might make their blood unsafe to use. The screening includes testing for diseases that can be transmitted by a blood transfusion, including HIV and viral hepatitis. The donor is also asked about medical history and given a short physical examination to make sure that the donation is not hazardous to his or her health. How often a donor can give varies from days to months based on what he or she donate and the laws of the country where the donation takes place.
The amount of blood drawn and the methods vary, but a typical donation is 500 milliliters (or approximately one US pint) of whole blood. The collection can be done manually or with automated equipment that only takes specific portions of the blood. Most of the components of blood used for transfusions have a short shelf life, and maintaining a constant supply is a persistent problem.
Types of donation
Blood donations are divided into three groups based on who will receive the collected blood. An allogeneic (also called homologous) donation is when a donor gives blood for storage at a blood bank for transfusion to an unknown recipient. A directed or replacement donor donation is when a person, often a family member, donates blood for transfusion to a specific individual. Directed donations are rare in developed countries like Canada but are common in developing countries such as Ghana. The third kind is when a person has blood stored that will be transfused back to the donor at a later date, usually after surgery. This is called an autologous donation. Blood that is used to make medications can be made from allogeneic donations or from donations exclusively used for manufacturing.
The actual process varies according to the laws of the country, and recommendations to donors vary according to the collecting organization. The World Health Organization gives recommendations for blood donation policies, but in developing countries many of these are not followed. For example, the recommended testing requires laboratory facilities, trained staff, and specialized reagents, all of which may not be available or too expensive in developing countries.
An event where donors come to give allogeneic blood is sometimes called a blood drive or a blood donor session. These can occur at a blood bank but they are often set up at a location in the community such as a shopping center, workplace, school, or house of worship.
Donors are typically required to give consent for the process and this requirement means that minors cannot donate without parental consent. In some countries, answers are associated with the donor's blood, but not name, to provide anonymity; in others, such as the United States, names are kept to create lists of ineligible donors. If a potential donor does not meet these criteria, they are deferred. This term is used because many donors that are ineligible may be allowed to donate later.
The donor's race or ethnic background is sometimes important since certain blood types, especially rare ones, are more common in certain ethnic groups. Historically, donors were segregated or excluded on race, religion, or ethnicity, but this is no longer a standard practice.
Donors are screened for health risks that might make the donation unsafe for the recipient. Some of these restrictions are controversial, such as restricting donations from men who have sex with men for HIV risk. Autologous donors are not always screened for recipient safety problems since the donor is the only person who will receive the blood. Donors are also asked about medications such as dutasteride since they can be dangerous to a pregnant woman receiving the blood.
Donors are examined for signs and symptoms of diseases that can be transmitted in a blood transfusion, such as HIV, malaria, and viral hepatitis. Screening may extend to questions about risk factors for various diseases, such as travel to countries at risk for malaria or variant Creutzfeldt-Jakob Disease (vCJD). These questions vary from country to country. For example, while Québec may defer donors who lived in the United Kingdom for risk of vCJD, donors in the United Kingdom are only restricted for vCJD risk if they have had a blood transfusion in the United Kingdom.
The donor is also examined and asked specific questions about their medical history to make sure that donating blood isn't hazardous to their health. The donor's hematocrit or hemoglobin level is tested to make sure that the loss of blood will not make them anemic, and this check is the most common reason that a donor is ineligible. Pulse, blood pressure, and body temperature are also evaluated. Elderly donors are sometimes also deferred on age alone because of health concerns. The safety of donating blood during pregnancy has not been studied thoroughly and pregnant women are usually deferred.
The donor's blood type must be determined if the blood will be used for transfusions. The collecting agency usually identifies whether the blood is type A, B, AB, or O and the donor's Rh (D) type and will screen for antibodies to less common antigens. More testing, including a crossmatch, is usually done before a transfusion. Group O is often cited as the "universal donor" but this only refers to red cell transfusions. For plasma transfusions the system is reversed and AB is the universal donor type.
Most blood is tested for diseases, including some STDs. The tests used are high-sensitivity screening tests and no actual diagnosis is made. Some of the test results are later found to be false positives using more specific testing. False negatives are rare, but donors are discouraged from using blood donation for the purpose of anonymous STD screening because a false negative could mean a contaminated unit. The blood is usually discarded if these tests are positive, but there are some exceptions, such as autologous donations. The donor is generally notified of the test result.
Donated blood is tested by many methods, but the core tests recommended by the World Health Organization are these four:
- Hepatitis B Surface Antigen
- Antibody to Hepatitis C
- Antibody to HIV, usually subtypes 1 and 2
- Serologic test for Syphilis
The WHO reported in 2006 that 56 out of 124 countries surveyed did not use these basic tests on all blood donations.
A variety of other tests for transfusion transmitted infections are often used based on local requirements. Additional testing is expensive, and in some cases the tests are not implemented because of the cost. These additional tests include other infectious diseases such as West Nile Virus. Sometimes multiple tests are used for a single disease to cover the limitations of each test. For example, the HIV antibody test will not detect a recently infected donor, so some blood banks use a p24 antigen or HIV nucleic acid test in addition to the basic antibody test to detect infected donors during that period. Cytomegalovirus is a special case in donor testing in that many donors will test positive for it. The virus is not a hazard to a healthy recipient, but it can harm infants and other recipients with weak immune systems.
Obtaining the blood
There are two main methods of obtaining blood from a donor. The most frequent is simply to take the blood from a vein as whole blood. This blood is typically separated into parts, usually red blood cells and plasma, since most recipients need only a specific component for transfusions. The other method is to draw blood from the donor, separate it using a centrifuge or a filter, store the desired part, and return the rest to the donor. This process is called apheresis, and it is often done with a machine specifically designed for this purpose.
For direct transfusions a vein can be used but the blood may be taken from an artery instead. In this case, the blood is not stored and is pumped directly from the donor into the recipient. This was an early method for blood transfusion and is rarely used in modern practice. It was phased out during World War II because of problems with logistics, and doctors returning from treating wounded soldiers set up banks for stored blood when they returned to civilian life.
Site preparation and drawing blood
The blood is drawn from a large arm vein close to the skin, usually the median cubital vein on the inside of the elbow. The skin over the blood vessel is cleaned with an antiseptic such as iodine or chlorhexidine to prevent skin bacteria from contaminating the collected blood and also to prevent infections where the needle pierced the donor's skin.
A large needle is used to minimize shearing forces that may physically damage red blood cells as they flow through the needle. A tourniquet is sometimes wrapped around the upper arm to increase the pressure of the blood in the arm veins and speed up the process. The donor may also be prompted to hold an object and squeeze it repeatedly to increase the blood flow through the vein.
The most common method is collecting the blood from the donor's vein into a container. The amount of blood drawn varies from 200 milliliters to 550 milliliters depending on the country, but 450-500 milliliters is typical. The blood is usually stored in a plastic bag that also contains sodium citrate, phosphate, dextrose, and sometimes adenine. This combination keeps the blood from clotting and preserves it during storage. Other chemicals are sometimes added during processing.
The plasma from whole blood can be used to make plasma for transfusions or it can also be processed into other medications using a process called fractionation. This was a development of the dried plasma used to treat the wounded during World War II and variants on the process are still used to make a variety of other medications. 
- Main article: Apheresis
Usually the component returned is the red blood cells, the portion of the blood that takes the longest to replace. Using this method an individual can donate plasma or platelets much more frequently than they can safely donate whole blood. These can be combined, with a donor giving both plasma and platelets in the same donation.
Platelets can also be separated from whole blood, but they must be pooled from multiple donations. From three to ten units of whole blood are required for a therapeutic dose. Plateletpheresis provides at least one full dose from each donation.
Plasmapheresis is frequently used to collect source plasma that is used for manufacturing into medications much like the plasma from whole blood. Plasma collected at the same time as plateletpheresis is sometimes called concurrent plasma.
Recovery and time between donations
Donors are usually kept at the donation site for 10–15 minutes after donating since most adverse reactions take place during or immediately after the donation.  Blood centers typically provide light refreshments such as tea and biscuits or a lunch allowance to help the donor recover. The needle site is covered with a bandage and the donor is directed to keep the bandage on for several hours.
Donated plasma is replaced after 2-3 days. Red blood cells are replaced by bone marrow into the circulatory system at a slower rate, on average 36 days in healthy adult males. In that study, the range was 20 to 59 days for recovery. These replacement rates are the basis of how frequently a donor can give blood.
Plasmapheresis and plateletpheresis donors can give much more frequently because they do not lose significant amounts of red cells. The exact rate of how often a donor can donate differs from country to country. For example, plasma donors in the United States are allowed to donate large volumes twice a week and could nominally give 83 liters (about 22 gallons) in a year, whereas the same donor in Japan may only donate every other week and could only donate about 16 liters (about 4 gallons) in a year. Red blood cells are the limiting step for whole blood donations, and the frequency of donation varies widely. In Hong Kong it is from three to six months, in Australia it is twelve weeks, in the United States it is eight weeks and in the UK it is usually 16 weeks but can be as little as 12.
Donors are screened for health problems that would put them at risk for serious complications from donating. First-time donors, teenagers, and women are at a higher risk of a reaction. One study showed that 2% of donors had an adverse reaction to donation. Most of these reactions are minor. A study of 194,000 donations found only one donor with long-term complications. In the United States, a blood bank is required to report any death that might possibly be linked to a blood donation. An analysis of all reports from October 2004 to September 2006 evaluated 22 events and found no deaths related to donation, though one could not be ruled out.
Donors sometimes have adverse reactions to the sodium citrate used in apheresis collection procedures to keep the blood from clotting. Since the anticoagulant is returned to the donor along with blood components that are not being collected, it can bind the calcium in the donor's blood and cause hypocalcemia. These reactions tend to cause tingling in the lips, but may cause convulsions or more serious problems. Donors are sometimes given calcium supplements during the donation to prevent these side effects.
In apheresis procedures, the red blood cells are often returned. If this is done manually and the donor receives the blood from a different person, a transfusion reaction can take place. Manual apheresis is extremely rare in the developed world because of this risk and automated procedures are as safe as whole blood donations.
The final risk to blood donors is from equipment that has not been properly sterilized. In most cases, the equipment that comes in direct contact with blood is discarded after use. Re-used equipment was a significant problem in China in the 1990s, and up to 250,000 blood plasma donors may have been exposed to HIV from shared equipment.
Storage, supply and demand
The collected blood is usually stored as separate components, and some of these have short shelf lives. There are no storage solutions to keep platelets for extended periods of time, though some are being studied as of 2008, and the longest shelf life used is seven days. Red blood cells, the most frequently used component, have a shelf life of 35–42 days at refrigerated temperatures. This can be extended by freezing the blood with a mixture of glycerol but this process is expensive, rarely done, and requires an extremely cold freezer for storage. Plasma can be stored frozen for an extended period of time and is typically given an expiration date of one year and maintaining a supply is less of a problem.
The limited storage time means that it is difficult to have a stockpile of blood to prepare for a disaster. The subject was discussed at length after the September 11th attacks in the United States, and the consensus was that collecting during a disaster was impractical and that efforts should be focused on maintaining an adequate supply at all times. Blood centers in the U.S. often have difficulty maintaining even a three day supply for routine transfusion demands.
The World Health Organization recognizes World Blood Donor Day on 14th June each year to promote blood donation. This is the birthday of Karl Landsteiner, the scientist who discovered the ABO blood group system. As of 2008, the WHO estimated that more than 81 million units of blood were being collected annually.
Benefits and incentives
The World Health Organization set a goal in 1997 for all blood donations to come from unpaid volunteer donors, but as of 2006, only 49 of 124 countries surveyed had established this as a standard. Plasmapheresis donors in the United States are still paid for donations. A few countries rely on paid donors to maintain an adequate supply. Some countries, such as Tanzania, have made great strides in moving towards this standard, with 20 percent of donors in 2005 being unpaid volunteers and 80 percent in 2007, but 68 of 124 countries surveyed by WHO had made little or no progress. In some countries, for example Brazil, it is against the law to receive any compensation, monetary or otherwise, for the donation of blood or other human tissues.
In patients prone to iron overload, blood donation prevents the accumulation of toxic quantities. Blood banks in the United States must label the blood if it is from a therapeutic donor, so most do not accept donations from donors with any blood disease. Others, such as the Australian Red Cross Blood Service, accept blood from donors with hemochromatosis. It is a genetic disorder that does not affect the safety of the blood. Donating blood may reduce the risk of heart disease for men, but the link has not been firmly established.
Other incentives are sometimes added by employers, usually time off for the purposes of donating. Blood centers will also sometimes add incentives such as assurances that donors would have priority during shortages and there are other programs such as prize drawings for donors and rewards for organizers of successful drives. Most allogeneic blood donors donate as an act of charity and do not expect to receive any direct benefit from the donation.
|This page uses Creative Commons Licensed content from Wikipedia (view authors).|
- Blood donation: What to expect. Mayo Clinic. URL accessed on 2008-12-03.
- M. E. Brecher, Editor (2005), AABB Technical Manual, fifteenth edition, Bethesda, MD: AABB, ISBN 1-56935-19607, p.98-103
- Directed Donation. Mayo Clinic. URL accessed on 2008-06-25.
- Wales PW, Lau W, Kim PC (May 2001). Directed blood donation in pediatric general surgery: Is it worth it?. J. Pediatr. Surg. 36 (5): 722–5.
- T. Brown "Strengthening Blood Systems In Africa: Progress Under PEPFAR and Remaining Challenges" AABB News. April, 1998:page 30
- Autologous (self-donated) Blood as an Alternative to Allogeneic (donor-donated) Blood Transfusion. AABB. URL accessed on 2008-06-25.
- Recovered Plasma. AABB. URL accessed on 2008-06-25.
- Giving Blood -> What to Expect. Australian Red Cross Blood Service. URL accessed on 2007-10-06.
- The Donation Experience. Canadian Blood Services. URL accessed on 2006-12-17.
- Tips for a Good Donation Experience. American Red Cross. URL accessed on 2006-12-17.
- WHO Blood Safety and Donation. World Health Organization. URL accessed on 2008-06-01.
- World Blood Donor Day 2006. World Health Organization. URL accessed on 2008-06-26.
- Sponsoring a Blood Drive. American Red Cross. URL accessed on 2008-06-25.
- Parental consent form. (pdf) Australian Red Cross Blood Service. URL accessed on 2008-06-01.
- FDA regulations on donor deferral. US Food and Drug Administration. URL accessed on 2008-06-01.
- Donors' Races to Be Sought To Identify Rare Blood Types. New York Times. URL accessed on 2008-06-01.
- Red Gold, Innovators and Pioneers. Public Broadcasting Service (United States). URL accessed on 2008-06-01.
- Drug Agency Reaffirms Ban on Gay Men Giving Blood. New York Times. URL accessed on 2009-03-26.
- Heim MU, Mempel W (1991). [The need for thorough infection screening in donors of autologous blood]. Beitr Infusionsther 28: 313–6.
- Avodart consumer information. US Food and Drug Administration. URL accessed on 2008-06-01.
- AABB Full-Length Donor History Questionnaire (UDHQ). AABB, FDA. URL accessed on 2008-06-25.
- Donor Qualification criteria. Héma-Québec, Canada. URL accessed on 2006-12-17.
- Guidelines for UK Blood Services. UK Blood and Tissue Services. URL accessed on 2008-06-01.
- Gómez-Simón A, Navarro-Núñez L, Pérez-Ceballos E, et al (Jun 2007). Evaluation of four rapid methods for hemoglobin screening of whole blood donors in mobile collection settings. Transfus. Apher. Sci. 36 (3): 235–42.
- Goldman M, Fournier E, Cameron-Choi K, Steed T (May 2007). Effect of changing the age criteria for blood donors. Vox Sang. 92 (4): 368–72.
- Donating - Frequently Asked Questions. Blood Bank of Alaska. URL accessed on 2008-06-01.
- Blood Type Test. WebMD.com. URL accessed on 2008-06-01.
- Plasma fact sheet. American Red Cross.
- Bhattacharya P, Chandra PK, Datta S, et al (Jul 2007). Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World J. Gastroenterol. 13 (27): 3730–3.
- Testing of Donor Blood for infectious disease. AABB. URL accessed on 2008-06-25.
- R. Miller, P.E. Hewitt, R. Warwick, M.C. Moore, B. Vincent (1998). Review of counselling in a transfusion service: the London (UK) experience. Vox Sang 74 (3): 133–9.
- Advisory Committe on MSBTO, 28 June 2005. URL accessed on 2008-06-01.
- Precautionary West Nile virus blood sample testing. Héma-Québec, Canada. URL accessed on 2006-12-17.
- Circular of Information for use of Blood and Blood Products. (pdf) AABB, ARC, America's Blood Centers. Cite error: Invalid
<ref>tag; name "Circular of Information" defined multiple times with different content
- Red blood cell transfusions in newborn infants: Revised guidelines. Canadian Paediatric Society (CPS). URL accessed on 2007-02-02.
- Sagi E, Eyal F, Armon Y, Arad I, Robinson M (Nov 1981). Exchange transfusion in newborns via a peripheral artery and vein. Eur. J. Pediatr. 137 (3): 283–4.
- Blood on the Hoof. Public Broadcasting Service. URL accessed on 2008-06-25.
- ISBT Quarterly Newsletter, June 2006, "A History of Fresh Blood", page 15. (pdf) International Society of Blood Transfusion (ISBT/SITS). URL accessed on 2008-07-31.
- Lee CK, Ho PL, Chan NK, Mak A, Hong J, Lin CK (Oct 2002). Impact of donor arm skin disinfection on the bacterial contamination rate of platelet concentrates. Vox Sang. 83 (3): 204–8.
- M. L. Turgeon (2004). Clinical Hematology: Theory and Procedures, fourth, 30, Lippincott Williams & Wilkins. URL accessed 2008-06-21.
- One major manufacturer of collection sets uses a 16 gauge (1.651 mm) size Blood banking laboratory supplies. Genesis BPS. URL accessed on 2008-06-01.
- What is Hemolysis?. Becton-Dickinson. URL accessed on 2008-06-01.
- Akerblom O, Kreuger A (1975). Studies on citrate-phosphate-dextrose (CPD) blood supplemented with adenine. Vox Sang. 29 (2): 90–100.
- Plasma Equipment and Packaging, and Transfusion Equipment. Office of Medical History (OTSG). URL accessed on 2008-06-19.
- Medicines derived from human plasma. Sanquin Blood Supply Foundation. URL accessed on 2008-06-01.
- Indications for Platelet Transfusion Therapy. Southeastern Community Blood Center. URL accessed on 2008-06-10.
- "Double Up to Save Lives". United Blood Services. URL accessed on 2007-02-23.
- "Double the Difference". American Red Cross (Greater Chesapeake and Potomac). URL accessed on 2007-02-23.
- Eder AF, Hillyer CD, Dy BA, Notari EP, Benjamin RJ (May 2008). Adverse reactions to allogeneic whole blood donation by 16- and 17-year-olds. JAMA 299 (19): 2279–86.
- Report on the promotion by Member States of voluntary unpaid blood donation. Commission of the European Communities. URL accessed on 2008-06-26.
- Donating Apheresis and Plasma. Community Blood Center. URL accessed on 2008-06-11.
- Pottgiesser T, Specker W, Umhau M, Dickhuth HH, Roecker K, Schumacher YO (Jul 2008). Recovery of hemoglobin mass after blood donation. Transfusion 48 (7): 1390–7.
- Blood Products Advisory Committee, 12 December 2003. URL accessed on 2008-06-01.
- Blood Donation. Hong Kong Red Cross Blood Transfusion Service. URL accessed on 2008-06-01.
- Before and after giving blood. Australian Red Cross Blood Service. URL accessed on 2008-06-01.
- Donating Whole Blood. Lane Memorial Blood Bank. URL accessed on 2008-06-01.
- Who can't give blood. National Blood Service for England and Wales. URL accessed on 2009-02-026.
- A.F. Eder, C.D. Hillyer, B.A. Dy, E.P. Notari, R.J. Benjamin (May 2008). Adverse reactions to allogeneic whole blood donation by 16- and 17-year-olds. JAMA 299 (19): 2279–86.
- Yuan S, Gornbein J, Smeltzer B, Ziman AF, Lu Q, Goldfinger D (Jun 2008). Risk factors for acute, moderate to severe donor reactions associated with multicomponent apheresis collections. Transfusion 48 (6): 1213–9.
- Adverse Effect of Blood Donation, Siriraj Experience. American Red Cross. URL accessed on 2008-06-01.
- B. Newman, S. Graves (2001). A study of 178 consecutive vasovagal syncopal reactions from the perspective of safety. Transfusion 41 (12): 1475–9.
- Fatalities Reported to FDA. US Food and Drug Administration. URL accessed on 2008-06-01.
- Wiltbank TB, Giordano GF, Kamel H, Tomasulo P, Custer B (May 2008). Faint and prefaint reactions in whole-blood donors: an analysis of predonation measurements and their predictive value. Transfusion 48: 1799.
- Ranasinghe E, Harrison JF (Jun 2000). Bruising following blood donation, its management and the response and subsequent return rates of affected donors. Transfus Med 10 (2): 113–6.
- Bolan CD, Greer SE, Cecco SA, Oblitas JM, Rehak NN, Leitman SF (Sep 2001). Comprehensive analysis of citrate effects during plateletpheresis in normal donors. Transfusion 41 (9): 1165–71.
- Jerome H. Holland Laboratory for the Biomedical Sciences Volunteer Research Blood Program (RBP). American Red Cross. URL accessed on 2008-06-01.
- Wiltbank TB, Giordano GF (Jun 2007). The safety profile of automated collections: an analysis of more than 1 million collections. Transfusion 47 (6): 1002–5.
- Blood Donor Information Leaflet. Irish Blood Transfusion Service. URL accessed on 2008-06-01.
- Keeping China's blood supply free of HIV. US Embassy, Beijing. URL accessed on 2008-06-01.
- Cohen J (Jun 2004). HIV/AIDS in China. An unsafe practice turned blood donors into victims. Science (journal) 304 (5676): 1438–9.
- In Vitro Evaluation of Buffy Coat Derived Platelet Concentrates in SSP+ Platelet Storage Medium. Transfusion Medicine (Blackwell Publishing. URL accessed on 2008-06-01.
- Transfusion Handbook, summary information for Platelets. National Blood Transfusion Committee. URL accessed on 2008-06-02.
- Lockwood WB, Hudgens RW, Szymanski IO, Teno RA, Gray AD (Nov 2003). Effects of rejuvenation and frozen storage on 42-day-old AS-3 RBCs. Transfusion 43 (11): 1527–32.
- Transfusion handbook, Summary information for Red Blood Cells. National Blood Transfusion Committee. URL accessed on 2008-06-02.
- Transfusion of Fresh Frozen Plasma, products, indications. Agence française de sécurité sanitaire des produits de santé. URL accessed on 2008-06-02.
- Maintaining an Adequate Blood Supply Is Key to Emergency Preparedness. Government Accountability Office. URL accessed on 2008-06-01.
- Current status of America's Blood Centers blood supply. America's Blood Centers.
- World Blood Donor Day. World Health Organization. URL accessed on 2008-06-01.
- Blood Plasma Safety. GAO. URL accessed on 2008-06-01.
- G. A. Schmunis (corresponding author for PAHO) (Jan 2005). Safety of the Blood Supply in Latin America. Clinical Microbiology Reviews 18: 12.
- L. Fusco "From Latin America to Asia, Rising Above Difficulties, Achieving New Heights" AABB News. April, 1998:page 30
- Fields AC, Grindon AJ (1999). Hemochromatosis, iron, and blood donation: a short review. Immunohematology 15 (3): 108–12.
- Variances for Blood Collection from Individuals with Hereditary Hemochromatosis. US Food and Drug Administration. URL accessed on 2007-07-18.
- Hereditary Hemochromatosis: Perspectives of Public Health, Medical Genetics, and Primary Care. CDC Office of Public Health Genomics. URL accessed on 2008-06-03.
- Tuomainen TP, Salonen R, Nyyssönen K, Salonen JT (Mar 1997). Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland. BMJ 314 (7083): 793–4.
- Guidelines for Implementation of Employee Blood Donation Leave. New York State Department of Labor. URL accessed on 2008-06-01.
- Incentives program for blood donors and organizers. American Red Cross Connecticut Blood Services Region. URL accessed on 2008-06-01.
- Steele WR, Schreiber GB, Guiltinan A, et al (Jan 2008). The role of altruistic behavior, empathetic concern, and social responsibility motivation in blood donation behavior. Transfusion 48 (1): 43–54.